GALT - Galectin Therapeutics Stock Trading

Galectin is a clinical development stage biopharmaceutical company based in Norcross, Georgia, that is targeting fibrotic diseases and cancer with novel galectin inhibitor compounds. Galectins are a class of proteins made by many cells in the body and are important therapeutic targets because they are the mediators of fundamental biologic mechanisms in pathological processes. Galectin Therapeutics leverages its extensive scientific knowledge of galectins to advance their discovery program including research and discovery of new compounds. Through a relationship with a world class research program at the University of Georgia, the Company focuses on the discovery of new carbohydrate molecules that can be used in the therapy of diseases where galectin proteins play a major role including cancer and inflammatory and fibrotic disorders.